FIELD: medicine, ophthalmology, ophthalmooncology. SUBSTANCE: method deals with immunohistochemical assay for the cells of removed tumor at estimating the percentage of nuclear Flt receptor-expressing immunopositive cells. At revealing the ratio to the total number of tumor cells being below or equal to 33% one should predict high probability of metastasis. The method provides adequate therapy and prolongs life duration in severe patients. EFFECT: higher efficiency of prediction. 1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 2001 |
|
RU2197731C2 |
METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 1999 |
|
RU2157998C1 |
METHOD FOR PREDICTING CLINICAL DEVELOPMENT COURSE OF UVEAL MELANOMA | 2001 |
|
RU2192812C1 |
METHOD FOR PREDICTING UVEITIC MELANOMA CLINICAL COURSE | 1999 |
|
RU2149404C1 |
METHOD OF REVEALING LATENT METASTATIC SPREAD IN PATIENTS WITH UVEAL MELANOMA | 1998 |
|
RU2147373C1 |
METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2169006C1 |
METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2175242C1 |
METHOD FOR PREDICTING CLINICAL DEVELOPMENT COURSE OF UVEAL MELANOMA | 1998 |
|
RU2146823C1 |
METHOD FOR PREDICTING THE UNFAVORABLE COURSE OF UVEAL MELANOMA ASSOCIATED WITH A MALIGNANT MICROENVIRONMENT | 2019 |
|
RU2709214C1 |
METHOD FOR PREDICTION OF SURVIVAL RATE AFTER ENUCLEATION WITH UVEAL MELANOMA DEVELOPED TO EQUATOR | 2024 |
|
RU2822319C1 |
Authors
Dates
2002-11-20—Published
2001-05-23—Filed